Looking Into Regeneron Pharmaceuticals's Recent Short Interest
Portfolio Pulse from Benzinga Insights
Regeneron Pharmaceuticals's (NYSE:REGN) short percent of float has fallen 11.28% since its last report, with 1.08 million shares sold short, which is 1.18% of all regular shares available for trading. This decrease in short interest could signal a more bullish sentiment towards the stock. However, it does not necessarily mean that the stock price will rise in the near term. Compared to its peers, Regeneron has less short interest.
July 19, 2023 | 5:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Regeneron Pharmaceuticals's short interest has decreased, potentially indicating a more bullish sentiment. However, this does not guarantee a rise in stock price in the near term.
A decrease in short interest often indicates a more bullish sentiment towards a stock, as it means fewer traders are betting on the stock's price to fall. However, this does not necessarily translate into a rise in stock price, as other market factors also play a role. Therefore, while the news is relevant for Regeneron Pharmaceuticals, its impact on the stock price is uncertain.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100